| Date | Title | Description | Source |
| 30.04.2024 | Innovent Announces the Appointment of Dr. Samuel Zhang as Gl... | SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Inno... | en.prnasia... |
| 27.04.2024 | The Melanoma Research Foundation to host the DC Miles for Me... | 2024 DC Miles for Melanoma 5K
The Melanoma Research Foundation (MRF) is thrilled to announce the nex... | prweb.com/... |
| 27.04.2024 | India becoming attractive for clinical trials, says pharma i... | - | business-s... |
| 24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest ... | - | business-s... |
| 24.04.2024 | Govt expands committee for drugs, medical devices pricing re... | - | business-s... |
| 20.04.2024 | The Melanoma Research Foundation to host the New England Mil... | New England Miles for Melanoma
The Melanoma Research Foundation (MRF) is thrilled to announce one of... | prweb.com/... |
| 15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - | labusiness... |
| 11.04.2024 | Nuevocor Strengthens Leadership Team with Appointment of Joh... | SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnol... | en.prnasia... |
| 02.04.2024 | Jay Appel, Chief Innovation & Growth Officer at The Bloc... | NEW YORK, April 2, 2024 /PRNewswire/ -- The Bloc, a renowned global health-native agency, is proud t... | salamancap... |
| 20.03.2024 | Startup Lands $150M for Delicate Dance Between Cancer Cells ... | Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of ... | medcitynew... |
| 19.03.2024 | IU lands $20M donation to establish lung cancer research cen... | - | ibj.com/ar... |
| 19.03.2024 | AstraZeneca Joins Radiopharma Deals Spree With $2B Fusion Ac... | AstraZeneca is following in the footsteps of some of its big pharmaceutical company peers, plunking ... | medcitynew... |
| 18.03.2024 | Everest Medicines Strengthens Management Team with Appointme... | SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or t... | en.prnasia... |
| 13.03.2024 | Cancer Immunotherapy Market Research 2024: The Race for the ... | - | globenewsw... |
| 13.03.2024 | Anxiety Disorder Treatment Market Size and Share Analysis, T... | Anxiety Disorder Treatment Market
Anxiety Disorder Treatment Market to Reach $15.89 Billion by 2030,... | einpresswi... |
| 13.03.2024 | Chronic Myeloid Leukemia Treatment Market On A Growth Trajec... | - | globenewsw... |
| 13.03.2024 | После вмешательства генпрокурора РФ 68 южноуральцев обеспече... | - | kommersant... |
| 11.03.2024 | Nitrase Therapeutics Unveils Pioneering Antibody Candidate f... | -Nitrase’s first-in-class antibody found to significantly delay progression of Parkinson’s disease i... | svhealthin... |
| 11.03.2024 | CytomX Therapeutics Reports 2023 Financial Results and Provi... | - CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data in solid tumors anticipated... | einpresswi... |
| 08.03.2024 | Peptide Therapeutics Market Size, Share, Revenue, Trends And... | Peptide Therapeutics Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business R... | einpresswi... |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID... | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of ... | einpresswi... |
| 08.03.2024 | Chemotherapy Induced Peripheral Neuropathy Treatment Global ... | - | globenewsw... |
| 07.03.2024 | United in the Fight Against Colorectal Cancer | - | globenewsw... |
| 06.03.2024 | Myeloproliferative Disorders Drugs Market Report 2024-2033: ... | - | globenewsw... |
| 05.03.2024 | Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report... | - | globenewsw... |
| 04.03.2024 | Head and Neck Cancer Market Size, Trends, Industry Statistic... | BROOKLYN, NY, USA, March 4, 2024 /EINPresswire.com/ -- What is the market for head and neck cancer?
... | einpresswi... |
| 04.03.2024 | Analgesics Market Set to Surge USD 50.7 Bn by 2028 | 6.6% CA... | Analgesics Market 2024
PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- What is ... | einpresswi... |
| 08.01.2024 | Bristol Myers Squibb invests in GlycoEra | | startuptic... |
| 11.12.2023 | Bristol-Myers Squibb Co., Ltd. Holds a charity bike ride and... | Bristol-Myers Squibb Co., Ltd.
Charity bike ride held and approximately 23 million yen donated to Ca... | re-how.net... |
| 26.10.2023 | Pfizer’s twice daily pill for obesity hopes to rival Wegovy ... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 20.10.2023 | Teddi Mellencamp Gets Naked for Melanoma Awareness Month | WASHINGTON (PRWEB) May 01, 2023 -- The Melanoma Research Foundation (MRF) is pleased to announce the... | prweb.com/... |
| 16.10.2023 | AstronauTx, developing treatments for Alzheimer's, raises $5... | The startup works in partnership with UCL and is backed by Novartis and UK gov't funds
In the United... | vator.tv/n... |
| 10.08.2023 | The Melanoma Research Foundation to Host the 2023 Philadelph... | Philadelphia Miles for Melanoma
PHILADELPHIA (PRWEB) August 10, 2023
The Melanoma Research Foundatio... | prweb.com/... |
| 20.07.2023 | Majic WMJI Morning Show Host Mark Nolan to Emcee Melanoma Re... | Register today for the Miles for Melanoma Cleveland 5k!
CLEVELAND (PRWEB) July 20, 2023
The Melanoma... | prweb.com/... |
| 05.07.2023 | Emmy Award-Winning Journalist and Current Anchor for WGN Mid... | Chicago, IL (PRWEB) July 05, 2023
The Melanoma Research Foundation (MRF) is thrilled to announce tha... | prweb.com/... |
| 23.06.2023 | Aenova opens new drug production building in Regensburg for ... | The Aenova Group has opened a new production building at its Regensburg site for 25 million euros fo... | bio-m.org/... |
| 01.05.2023 | Teddi Mellencamp Gets Naked for Melanoma Awareness Month | WASHINGTON (PRWEB) May 01, 2023
The Melanoma Research Foundation (MRF) is pleased to announce the la... | prweb.com/... |
| 27.04.2023 | The Melanoma Research Foundation Launches 2023 Miles for Mel... | WASHINGTON (PRWEB) April 27, 2023
The Melanoma Research Foundation (MRF) is proud to announce the re... | prweb.com/... |
| 27.12.2022 | Sarah LaCivita Awarded Aspire2STEAM Scholarship | Sarah LaCivita, Aspire2STEAM Scholarship Recipient
CompTIA.org, a Global Leader in IT Education and ... | einpresswi... |
| 25.10.2022 | The Robert A. Winn Diversity in Clinical Trials Award Progra... | PRINCETON, NJ / ACCESSWIRE / October 25, 2022 / The Bristol Myers Squibb Foundation (BMSF), together... | accesswire... |
| 08.06.2022 | French AI biotech startup Owkin gets $80-million shot from B... | Parisian AI biotech unicorn Owkin has brought in $80 million as it partners with the US-based pharma... | tech.eu/20... |
| 11.05.2022 | The Melanoma Research Foundation to host the 2022 Washington... | WASHINGTON (PRWEB) May 11, 2022
The Melanoma Research Foundation (MRF) is thrilled to announce its a... | prweb.com/... |
| 28.04.2022 | CURE Media Group Announces Margaret Campbell, B.S.N., RN, as... | ANAHEIM, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedi... | globenewsw... |
| 31.01.2022 | The Future Of Medicine: Fighting Deadly Diseases With Smart ... | How the future of healthcare is shaped by passive data and intelligent algorithms getty | forbes.com... |
| 20.01.2022 | Bristol Myers Squibb : Receives Approval for Abecma (idecabt... | TOKYO, January 20, 2022 -- Bristol-Myers Squibb K.K. today announced that Japan's Ministry of Health... | marketscre... |
| 02.11.2021 | OPDIVO® Receives Two New Health Canada Approvals for: Use wi... | MONTREAL, Nov. 2, 2021 /CNW/ - Today Bristol Myers Squibb Canada announces two recent Health Canada ... | marketscre... |
| 27.10.2021 | Third Quarter 2021 Earnings Release | Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
Reports Third Quarter Revenues... | marketscre... |
| 20.10.2021 | Global pharma companies grow interest in Swiss Lifesciences | | startuptic... |
| 07.10.2021 | Despite drug’s Phase 2 failure in ulcerative colitis, BMS ke... | A drug that Bristol Myers Squibb is developing for use across a wide range of autoimmune diseases ha... | medcitynew... |
| 05.08.2021 | A Texas-based pharma has enlisted Catalent for oral sol... | CDMO Catalent has kept busy with mergers and acquisitions, but Monday, it announced a colla... | endpts.com... |
| 25.05.2021 | BRISTOL-MYERS SQUIBB COMPANY
Bristol Myers Squibb : Foundat... | Four Projects in Brazil Receive Inaugural Grants to Improve Delivery of Care for Lung Cancer and Mel... | marketscre... |
| 30.04.2021 | CURE Media Group Announces Maria Lim, B.S.N., RN, OCN, BMTCN... | | prnewswire... |
| 19.03.2021 | U.S. Food and Drug Administration (FDA) Accepts Bristol Myer... | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 19, 2021--
Bristol Myers Squibb (NYSE: BMY) today announced th... | oaoa.com/n... |
| 02.03.2021 | Bristol Myers Squibb to Participate in Barclays Virtual Glob... | NEW YORK--(BUSINESS WIRE)--Mar 2, 2021--
Bristol Myers Squibb (NYSE: BMY) today announced that the c... | oaoa.com/n... |
| 26.02.2021 | Bristol Myers Squibb Receives Positive CHMP Opinion for Opdi... | PRINCETON, N.J.--(BUSINESS WIRE)--Feb 26, 2021--
Bristol Myers Squibb (NYSE: BMY) today announced th... | oaoa.com/n... |
| 24.02.2021 | Bristol Myers Squibb to Take Part in the Cowen Virtual 41st ... | NEW YORK--(BUSINESS WIRE)--Feb 24, 2021--
Bristol Myers Squibb (NYSE: BMY) today announced that the ... | oaoa.com/n... |
| 24.02.2021 | Bristol Myers Squibb Donates $11 Million to Advance Health E... | PRINCETON, N.J.--(BUSINESS WIRE)--Feb 24, 2021--
Bristol Myers Squibb (NYSE: BMY) today announced it... | oaoa.com/n... |
| 09.02.2021 | How Companies Are Trying To Discourage And Detect Misconduct... | White collar criminal under arrestgetty | forbes.com... |
| 13.11.2020 | How a child's wish brings hope while fighting cancer during ... | Sorry, but your browser does not support the video tag.
(BPT) - The COVID-19 pandemic is difficult i... | salamancap... |
| 08.04.2020 | Covid-19 roundup: EU‘s top scientist resigns in rebuke t... | As the novel coronavirus took root around the globe in early March, the European Union’s top s... | endpts.com... |
| 23.01.2020 | Pascal Soriot and AstraZeneca commit to zero-carbon b... | Pascal Soriot has spent more than 20 years at the top of an industry recently found to emit m... | endpts.com... |
| 15.02.2018 | BMS antes up with Nektar deal worth $3.6B | In return, BMS gets to test whether NKTR-214 can help its existing immunotherapies treat more cancer... | medcitynew... |
| 04.01.2018 | Personal Genome Diagnostics Raises $75 Million | Personal Genome Diagnostics Inc. (PGDx) today announced a $75 million Series B financing co-led by n... | citybizlis... |
| 04.01.2018 | Bristol-Myers Squibb Leads $75M Series B For Personal Genome... | Personal Genome Diagnostics Inc. (PGDx) today announced a $75 million Series B financing co-led by n... | citybizlis... |
| 11.11.2016 | With $100 million buy, BMS targets “richest opportunity for ... | It’s all very early stage, said Peter Traber, chief medical officer, president and CEO of Galectin T... | medcitynew... |
| 24.11.2015 | Bristol-Myers Squibb Company Invests in Life Sciences Partne... | European healthcare investment firm Life Sciences Partners is teaming up with Bristol-Myers Squibb C... | finsmes.co... |
| 17.09.2015 | 6 of the biggest Delaware tech exits since 2001 | One of the signs of growth for an entrepreneurship community is its M&A activity. If you’re buil... | technical.... |
| 08.06.2015 | Five (non-cancer) areas Bristol-Myers Squibb is pursuing har... | The pharma giant has indeed found a sweet spot in immuno-oncology. Take a look at the recent success... | medcitynew... |
| 03.04.2015 | Analytical chemists: The life sciences industry wants YOU. | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently... | medcitynew... |
| 14.02.2013 | New biotech startup for therapeutic cancer vaccines includes... | The funding will help build Jounce’s product engine to develop biologics with a broad spectrum of ta... | medcitynew... |
| 13.02.2013 | 4 things to consider to position your biotechnology startup ... | To license or not to license When a big company is eyeing your technology, you need to be careful ho... | medcitynew... |
| 09.01.2013 | A biopharma startup’s antibody goes for migraine headache tr... | Latham said the company’s goal for the drug is to make it part of a monthly routine in which patient... | medcitynew... |
| 26.11.2012 | Pharma funded social network for oncolology nurses, care tea... | When my mother was a radiation technician in 1950s London and Philadelphia, there wasn’t much in the... | medcitynew... |
| 01.11.2012 | Immunotherapy developer secures $11.4 million for cervical c... | Solution/product: It is developing treatments for advanced cervical cancer and head and neck cancers... | medcitynew... |
| 16.07.2012 | 4 ways to think about GSK’s $3.6B offer for Human Genome Sci... | It has taken a few months and some hand-wringing, but Human Genome Sciences (NASDAQ:HGSI) has agreed... | medcitynew... |
| 21.06.2012 | FDA says no to J&J’s Xarelto for acute coronary syndrome... | “I want to see better evidence that this strategy of adding (Xarelto) … is robustly better for the p... | medcitynew... |
| 30.04.2012 | What does Warner Chilcott have to offer a potential buyer? | The company, which has U.S. offices in Rockaway, New Jersey, has several hormonal contraceptive and ... | medcitynew... |
| 26.04.2012 | Avandia to Alogliptin: A time line of recent FDA actions on ... | July 2010: An FDA advisory panel holds a two-day meeting to discuss safety issues surrounding GSK’s ... | medcitynew... |
| 27.03.2012 | Xarelto could set a new standard for treating pulmonary embo... | Pulmonary embolisms are one of the most common causes of death in a hospital. For every 100,000 peop... | medcitynew... |
| 21.03.2012 | Nasal spray osteoporosis drug firm raising $2.4 million in n... | The West Conshohocken, Pennsylvania company has said few alternatives are available to patients seek... | medcitynew... |
| 16.02.2012 | Life sciences companies make pharma pitches, hope for hits w... | Heat Bio. Heat’s lead drug program is an experimental lung cancer treatment in phase 2 clinical tria... | medcitynew... |
| 19.01.2012 | FDA rejects diabetes drug from Bristol-Myers Squibb, AstraZe... | The FDA had delayed making a decision about the drug last October following an FDA advisory regulato... | medcitynew... |
| 02.12.2011 | Formula Pharmaceuticals raising $13 million for leukemia vac... | The vaccine would be classified as an orphan drug, treating a niche patient population of under 200,... | medcitynew... |
| 08.11.2011 | BMY extends drug discovery collaboration with Tranzyme | The funding in the extension will be under the same terms and conditions as under the existing partn... | medcitynew... |
| 26.10.2011 | FDA extends action date for type 2 diabetes drug | “Bristol-Myers Squibb and AstraZeneca are committed to dapagliflozin as a potential new therapeutic ... | medcitynew... |
| 11.10.2011 | Azelon secures $4.5 million in Series A funding, restructure... | The financing has prompted a restructuring of the company, formerly called Zelos Therapeutics.
Don H... | medcitynew... |
| 08.08.2011 | MRSA treatment from Cempra inching toward phase 3 trials (pr... | Now, Cempra is weighing options that include another venture round, or perhaps a partnership with a ... | medcitynew... |
| 27.07.2009 | A law firm for the life sciences brought to you by Craigslis... | Ghannoum compares his approach to New York-based Axiom Global, which touts the catch-phrase, “The ro... | medcitynew... |
| 02.05.2008 | Nordic Capital Fund VII and Avista Capital Partners Agree to... | New York, NY, May 2, 2008 – Bristol-Myers Squibb Company (NYSE:BMY) announced today it has signed a ... | avistacap.... |
| 17.12.2007 | Avista Capital Partners Agrees To Acquire Bristol-Myers Squi... | New York, NY, December 17, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partne... | avistacap.... |
| 24.09.2007 | Life sciences briefing: Monday, Sept. 24, 2007 | Featured companies: Adnexus Therapeutics, Bristol-Myers Squibb, Cellerix, Elixir Therapeutics, Genom... | venturebea... |
| 01.08.2007 | Tobira Therapeutics raises $31M to combat HIV | Princeton, N.J.’s Tobira Therapeutics, a newly formed biotech aiming to take on HIV, raised an impre... | venturebea... |
| - | FDA extends action date for type 2 diabetes drug | The U.S. Food and Drug Administration has delayed making a decision over Bristol-Myers Squibb Co. (N... | medcitynew... |
| - | BMY extends drug discovery collaboration with Tranzyme | Bristol-Myers Squibb (NYSE:BMY) is extending a drug discovery and development agreement with Tranzym... | medcitynew... |
| - | With $100 million buy, BMS targets “richest opportunity for ... | Bristol-Myers Squibb (BMS) has deepened its pipeline for fibrosis drugs with the acquisition of a ne... | medcitynew... |
| - | Analytical chemists: The life sciences industry wants YOU. | There’s a massive demand in pharma and biotech for analytical chemists, particularly those with an i... | medcitynew... |
| - | MRSA treatment from Cempra inching toward phase 3 trials (pr... | The growing prevalence of drug-resistant bacteria means a rise in so-called superbugs with no antibi... | medcitynew... |
| - | What does Warner Chilcott have to offer a potential buyer? | As Warner Chilcott (NASDAQ: WCRX) acknowledged in an announcement Monday that it is considering stra... | medcitynew... |
| - | Liver Cancer Awareness – Here’s What You Need to Know in 202... | Justin Chen Li, CEO of Helio Genomics
By the end of 2022, nearly 42,00 new cases of primary liver ca... | hitconsult... |
| - | Nasal spray osteoporosis drug firm raising $2.4 million in n... | A company with a nasal spray formulation to treat osteoporosis is raising $2.4 million as it seeks t... | medcitynew... |
